This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. Cancer anabolic metabolism inhibitors move into clinic. Nat Biotechnol 34, 794–795 (2016). https://doi.org/10.1038/nbt0816-794
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0816-794
- Springer Nature America, Inc.
This article is cited by
-
RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis
Signal Transduction and Targeted Therapy (2023)
-
Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model
Cancer & Metabolism (2020)
-
Tumour metabolism and its unique properties in prostate adenocarcinoma
Nature Reviews Urology (2020)
-
Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism
Nature Metabolism (2020)
-
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
Scientific Reports (2017)